Key Takeaways
- • Benchmark Electronics reported Q1 2026 revenue of $677 million, up 7% year-over-year, landing toward the high end of guidance with non-GAAP EPS of $0.58, demonstrating consistent operational execution despite seasonal headwinds.
- • Management raised full-year revenue growth outlook to 9–10%, up from prior mid-single-digit expectations, reflecting increased confidence in the company's multi-year trajectory and broad-based demand across end markets.
- • Medical segment revenue surged 24% year-over-year, establishing it as a structural growth engine; AC&C segment jumped 41% driven by AI-linked ramps in liquid cooling, high-performance compute, and clustered AI solutions.
- • EPS expected to grow faster than revenue on a full-year basis, signaling operational execution and disciplined expense control as key levers for margin expansion and earnings growth.
- • Stock surged 13.5% following the earnings beat, as the market validated management's customer-first strategic initiatives implemented over the prior two years and improved operational efficiency.
Summary
Benchmark Electronics delivered a strong first-quarter 2026 performance, posting revenue of $677 million, up 7% year-over-year and positioned at the high end of management guidance. Non-GAAP earnings per share reached $0.58, also near the upper bound of the $0.53–$0.59 outlook, demonstrating disciplined execution despite acknowledged cyclical and seasonal softness in certain business segments. The results reflected the effectiveness of the company's customer-centric strategies, which have been in place for over two years and have yielded measurable improvements in operational efficiency.
Management took a notably upbeat stance on the earnings call, raising full-year revenue growth guidance to 9–10% from prior mid-single-digit assumptions. This meaningful revision signals strengthened confidence in structural demand drivers and the company's multi-year growth trajectory. Executives emphasized broad-based demand, strong end-market outperformance, and solid cash generation as supporting pillars for the elevated outlook. Critically, management indicated that EPS is expected to grow faster than revenue on a full-year basis, with operational execution and tight expense control identified as primary levers for margin expansion and earnings leverage.
Segment performance underscored the diversity and resilience of Benchmark's revenue streams. The Medical segment delivered exceptional results, with revenue surging 24% year-over-year, establishing this division as a structural growth engine for the business. The AC&C (Advanced Computing & Connectivity) segment achieved even more dramatic acceleration, posting 41% revenue growth, driven primarily by AI-related demand ramps in liquid cooling solutions, high-performance compute infrastructure, and clustered AI systems. Management highlighted a recent award as Hewlett Packard Enterprise's 2026 Manufacturing Partner of the Year as external validation of operational excellence and strategic alignment with key customers in the technology and compute sectors.
The market's response was swift and decisive, with Benchmark shares surging 13.5% following the earnings announcement, reflecting investor validation of the company's strategic positioning and near-term momentum. The combination of a clean beat on near-term expectations and a material raise to full-year guidance—coupled with evidence of market leadership in high-growth AI and medical technology segments—positioned Benchmark favorably within the broader technology and industrial services landscape heading into the second quarter.
Management took a notably upbeat stance on the earnings call, raising full-year revenue growth guidance to 9–10% from prior mid-single-digit assumptions. This meaningful revision signals strengthened confidence in structural demand drivers and the company's multi-year growth trajectory. Executives emphasized broad-based demand, strong end-market outperformance, and solid cash generation as supporting pillars for the elevated outlook. Critically, management indicated that EPS is expected to grow faster than revenue on a full-year basis, with operational execution and tight expense control identified as primary levers for margin expansion and earnings leverage.
Segment performance underscored the diversity and resilience of Benchmark's revenue streams. The Medical segment delivered exceptional results, with revenue surging 24% year-over-year, establishing this division as a structural growth engine for the business. The AC&C (Advanced Computing & Connectivity) segment achieved even more dramatic acceleration, posting 41% revenue growth, driven primarily by AI-related demand ramps in liquid cooling solutions, high-performance compute infrastructure, and clustered AI systems. Management highlighted a recent award as Hewlett Packard Enterprise's 2026 Manufacturing Partner of the Year as external validation of operational excellence and strategic alignment with key customers in the technology and compute sectors.
The market's response was swift and decisive, with Benchmark shares surging 13.5% following the earnings announcement, reflecting investor validation of the company's strategic positioning and near-term momentum. The combination of a clean beat on near-term expectations and a material raise to full-year guidance—coupled with evidence of market leadership in high-growth AI and medical technology segments—positioned Benchmark favorably within the broader technology and industrial services landscape heading into the second quarter.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.